Fig. 3From: Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcomaa Recurrence-free survival rate. There were no significant differences in recurrence-free survival between patients with higher and lower PPARγ expression (p = 0.327). b Metastasis-free survival rate. Metastasis-free survival rate was significantly higher in patients with lower PPARγ expression than in those with higher PPARγ expression (p = 0.01)Back to article page